Compugen share jumps as loss again narrows
February 9, 2010, 8:30 pm 
R&D expenses of $1.6m last year were the drug development company’s largest expense. Read More »
Category: Globes Online »
Jewish Press International
R&D expenses of $1.6m last year were the drug development company’s largest expense. Read More »
Category: Globes Online »
